Company Encyclopedia
View More
name
Aterian
ATER.US
Aterian, Inc., together with its subsidiaries, operates as a technology-enabled consumer products company in North America, Chile, Colombia, Argentina, and internationally. The company offers home and kitchen appliances, kitchenware, air quality appliances, health and beauty products, and essential oils under the Squatty Potty, HomeLabs, Mueller Living, PurSteam, Healing Solutions, and Photo Paper Direct brand names. It primarily serves individual online consumers through online retail channels, such as Amazon and Walmart; Mercado Libre, owned and operated websites; and other marketplaces. The company was formerly known as Mohawk Group Holdings, Inc.
18.01 B
ATER.USMarket value -Rank by Market Cap -/-

Financial Score

22/11/2025 Update
C
Household AppliancesIndustry
Industry Ranking6/11
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-46.31%E
    • Profit Margin-15.72%D
    • Gross Margin56.10%B
  • Growth ScoreD
    • Revenue YoY-26.81%E
    • Net Profit YoY32.49%B
    • Total Assets YoY-23.00%E
    • Net Assets YoY-26.08%E
  • Cash ScoreE
    • Cash Flow Margin-636.00%E
    • OCF YoY-26.81%E
  • Operating ScoreA
    • Turnover1.7A
  • Debt ScoreC
    • Gearing Ratio43.61%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Aterian, Inc. Earnings Call: Mixed Outlook Amid Challenges

    Aterian, Inc.'s Q3 earnings call revealed mixed results. The company showed improvements in contribution margin and cost reductions, but faced a significant decline in net revenue due to tariffs and decreased consumer spending. Key highlights include a 700 basis point increase in contribution margin, an 80% reduction in adjusted EBITDA loss, and $5.5 million in annualized savings. AI implementation and new sales channels were also noted. However, net revenue fell by 27.5%, gross margin decreased, and net loss increased. Forward guidance focuses on growth and profitability amid ongoing challenges.

    Tip Ranks·
    US
    ATER
    -3.88%
    Tip Ranks·
    US
    ATER
    -3.88%

    Metagenomi, Inc. Reports Q3 2025 Financial Results

    Metagenomi, Inc. (MGX) reported its Q3 2025 financial results, showing a net loss of $20.4 million, up from $18.8 million a year prior. Revenue from collaborations fell to $8.7 million from $11.5 million, while operating expenses decreased to $31.5 million. The company holds $32.8 million in cash and $151.3 million in marketable securities. R&D expenses were $25.3 million as Metagenomi focuses on advancing its genetic medicine programs and genome editing technology for future growth.

    Tip Ranks·
    US
    MGX
    0.00%
    Tip Ranks·
    US
    MGX
    0.00%

    Aterian | 10-Q: FY2025 Q3 Revenue Misses Estimate at USD 19.02 M

    LB filings·
    US
    ATER
    -3.88%
    LB filings·
    US
    ATER
    -3.88%

    Aterian Inc. Amends Report on Executive Compensation Vote

    Aterian Inc. has amended its Form 8-K to clarify the frequency of future non-binding advisory votes on executive compensation, updating Item 5.07 of the original filing. No other changes were made to the report. This amendment was published via the SEC's EDGAR system on November 13, 2025.

    Reuters·
    US
    ATER
    -3.88%
    Reuters·
    US
    ATER
    -3.88%

    Aterian | 8-K: FY2025 Q3 Revenue Misses Estimate at USD 19.02 M

    LB filings·
    US
    ATER
    -3.88%
    LB filings·
    US
    ATER
    -3.88%
    Posts
    View More